ArticleJournal of gynecologic oncology2024

A retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer.

Hiromi Komazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.